
Neil Smart
@neil_j_smart
Consultant Colorectal Surgeon & Honorary Associate Professor, Exeter, UK. Editor in Chief, Colorectal Disease.
All views are my own.
ID: 3341521198
22-06-2015 14:42:58
26,26K Tweet
11,11K Followers
9,9K Following



Check👇for the updated @ACPGBI Strategy 2025- working together to improve patient care. 🙏 to all who contributed- many in the video below! Jim Khan Laura Hancock Nicola Eardley ACPGBI-PLG Steven D Wexner MD, PhD susan moug Dale Vimalachandran Antonino Spinelli ACPGBI-Education&Training The Dukes' Club Katie Adams (m. Waters)

UKIOG Research Committee is meeting 11/06/25; 15.00-16.30. If you have a research idea for Oesophago Gastric Cancer you would like to discuss DM me. Can be super early stage but we can support developing your idea and building your collaborations. Jessie Elliott

The influence of sacrocolporectopexy on pelvic anatomy assessed in an upright position using MRI OPEN ACCESS Colorectal Disease onlinelibrary.wiley.com/doi/full/10.11…




Important DCRjournal editorial from our susan galandiuk on the importance of integrity in journal submissions. journals.lww.com/dcrjournal/cit… ASCRS_1 #ASCRS25


We are looking for a full-time academic HPB surgeon to join our rapidly growing HPB practice at Mayo Clinic AZ Department of Surgery! The incoming surgeon will play a key role in further advancing the use of MIS techniques while continuing to provide expert open surgical care. jobs.mayoclinic.org/job/phoenix/he…




And we’re off! Welcome to #ASGBI2025! ASGBI President Mr Christian Macutkiewicz opens this year’s Congress alongside The Royal College of Surgeons of Edinburgh President Prof Rowan Parks. We’re honoured to host keynote speakers Prof Martin Griffiths and Prof Lydia Cairncross, what a start!!





Did you notice the announcement of the new international GRIFF Collaborative on ECF and IF? Don’t miss the initial survey later today to launch this exciting new venture - join and contribute please ASCRS_1 SAGES is in Tampa in 2026! @ACPGBI DCRjournal Dr Feza Remzi Fergal Fleming ASGBI

Lot of discussion to surely follow the DYNAMIC-III #ASCO25 oral. For rand trials of ctDNA-guided adj therapy in colon cancer to date: ➕trials DYNAMIC, CALGB 80702 (post-hoc) ➖DYNAMIC III, ALTAIR, COBRA Where do we go from here? OncoAlert Ibrahim Halil SAHIN, MD Michael Shusterman, MD ASCO

